Investigation on the Infection of HIV, HCV and Association High Risk Factors among Drug Users

Abstract

Abstract:

Objective: To understand the prevalence of HIV, HCV and estimate high risk factors among drug users in Dali Prefecture,
thereby to provide the scientific basis for promoting and perfecting the prevention work more accurately in a larger range. Methods:
The blood samples of 423 new drug users in Dali Detoxification Center from January 2015 to June 2015 were collected to detect the
infection status of HIV and HCV. Using the data in questionnaire survey and statistical methods, risk factors related to infection were
analyzed. Results: The infection rates among total 423 drug users were 19.4%（82/423）for HIV, 46.3%（196/423）for HCV. It is
found that 96.3%（79/82）of the 82 HIV positive had infected with HCV. Multiple factor analysis indicated that the prevalence of HIV
and HCV among drug users were positively related to drug using time, injection drug use, sharing needles. In addition, HCV infection
was associated positively with the age of drug users and the times and quantity of drug addicts using per day. Conclusion: All sorts of
high risk behavior associated with HIV and HCV infection result in the high HIV and HCV prevalence among drug users in Dali, which
accelerate the HIV and HCV prevalence among this group of people.

Key words: drug users, HIV infection, HCV infection, high risk factors

CLC Number:

R512.91

Li Ze, Liu Jizheng, Shen Yuanying. Investigation on the Infection of HIV, HCV and Association High Risk Factors among Drug Users[J]. J4, 2016, 1(10): 77-80.

References

〔1〕中国疾病预防控制中心.2014年12月全国艾滋病性病疫
情及主要防治工作进展〔J〕.中国艾滋病性病，2015，21
（2）：87.
〔2〕ZHANG Z H，YAO Y F，WU W L，et al. Hepatitis C Vi?
rus Genotype Diversity among Intravenous Drug Users in
YunnanProvince，SouthwesternChina〔J〕.PLoSONE，2013，
8（12）：e82598.
〔3〕BAO Y P，LIU Z M. Systematic review of HIV and HCV in?
fection among drug users in China〔J〕. International Jour?nal STD& AIDS，2009，20（6）：399-405.
〔4〕ZHOU Y H，YAO Z H，LIU F L，et al. High Prevalence of
HIV，HCV，HBV and Co-Infection and Associated Risk
Factors among Injecting Drug Users in Yunnan Province，
China〔J〕. PLoS ONE，2012，7（8）：e42937.
〔5〕ZHANG，B T，KAI N Z，JIN X K，et al. Infection with hu?
man immunodeficiency virus and hepatitis viruses in Chi?
nese drug addicts〔J〕. Epidemiology and Infection，1997，
119（3）：343-347.
〔6〕中华人民共和国卫生部.WS 213-2008丙型病毒性肝炎
诊断标准〔S〕.北京：人民卫生出版社，2008.
〔7〕中华人民共和国卫生部，联合国艾滋病规划署，世界卫
生组织.2011年中国艾滋病疫情估计〔J〕.中国艾滋病性
病，2012，18（1）：1-5.
〔8〕LU L，JIA M H，MA Y L，et al. The changing face of HIV
in China〔J〕. Nature，2008，455（7213）：609-611.
〔9〕JIA M H，LUO H B，MA Y L，et al. The HIV epidemic in
Yunnan Province，China，1989-2007〔J〕. J Acquir Im?
mune Defic Syndr，2010，53（1）：34-40.
〔10〕LI J H，HA T H，ZHANG C M，et al. The Chinese gov?
ernment’s response to drug use and HIV/AIDS：a review of
policies and programs〔J〕. Harm Reduct J，2010，7（1）：4-9.
〔11〕RUAN Y H，QIN G M，YIN L，et al. Incidence of HIV，
hepatitis C and hepatitis B viruses among injection drug
users in southwestern China：a 3-year follow-up study〔J〕.
AIDS，2007，21（8）：39-46.
〔12〕QUAN V M，GO V F，BERGENSTROM A，et al. Risks
for HIV，HBV，and HCV infections among male injection
drug users in northern Vietnam：a case-control study〔J〕.
AIDS Care，2009，21（1）：7-16.
〔13〕SOLOMON S S，SRIKRISHNAN A K，MEHTA S H，et al.
High prevalence of HIV，HIV/hepatitis C virus co-infec?
tion，and risk behaviors among injection drug users in
Chennai，India：a cause for concern〔J〕. J Acquir Im?
mune Defic Syndr，2008，49（3）：327-332.

[1]	Wang Ji, Bin Songtao, Li Ming, Tan Li. Ordinary COVID-19 Associated with HIV Infection: A Case Report and Literature Analysis [J]. Journal of Dali University, 2020, 5(10): 20-23.
[2]	WANG Xiao-Li, WANG Cong, WANG Tao- , LIU Qi- , GUO Li-Jun- , BAI Li. Analysis of Growth Curve and Generation Time of Oral Candida albicans from HIV-infected Individuals [J]. J4, 2014, 13(4): 14-18.